Hikma accuses Amarin of suppressing generic versions of heart pill
...By Brendan Pierson
(Reuters) - Generic drugmaker Hikma......…
0,501€
12,33%
Echtzeit-Aktienkurs Amarin Corp. PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Amarin Corp. PLC (Spons. ADRs) Aktie
Amarin tells shareholders to reject Sarissa proposals at upcoming meeting
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin holders should vote against Sarissa board nominees, proxy advisor ISS says
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy Cards
Sarissa Issued its False Release Hours After Receiving Confirmation That All Proxy Cards Were Being Accepted Sarissa Issued its False…
Amarin hits nine-month high amid proxy battle with Sarissa
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
Significantly Refreshed Board Overseeing Successful Execution of Amarins Transformation Plan to Drive Short- and Long-Term Value; Outmatches Sarissas Slate in…
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
Urges Shareholders to Vote “AGAINST” Sarissas Proposals on the WHITE Proxy Card...…
Amarin, ViewRay See Activist Action
Sarissa Capital is pushing to get a slate of directors on the board of pharmaceutical firm Amarin. Hudson Executive disclosed…
ADRs End Lower; Amarin, ArcelorMittal Trade Actively
ADRs End Lower; Amarin, ArcelorMittal Trade Actively...…
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise…
Why Amarin Stock Tumbled This Week
Amarins tussle with its largest stakeholder doesnt appear to be sitting well with shareholders....…
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
-- Board Refreshment Process Has Been Comprehensive, Independent and Transparent; Sarissas Candidates Are Not Qualified Versus Recently Appointed Board Members…
Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees
Sarissa Capital Management has sent a requisition notice to Amarin to call a general shareholder meeting and to appoint the investors…
Amarin says it will announce special meeting after largest shareholder demands one
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin wins positive views at Cantor on topline beat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AMARIN CORP PLCUK For: Jan 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin ADRs Rise 12% on 4Q, 2022 Preliminary Revenue Figures
Amarin ADRs Rise 12% on 4Q, 2022 Preliminary Revenue Figures...…
Amarin sees U.S. revenue stabilization amid generic thereat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
-- Company Delivers Fourth Consecutive Quarter of U.S. Revenue Stabilization, Positive Fourth Quarter Cash Flow and Continued Progress on European…
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
-- Dr. Stewart Brings More Than 30 Years of Cardiometabolic Academic and Industry Experience to Amarins Board –-...…
Form 8-K/A AMARIN CORP PLCUK For: Oct 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AMARIN CORP PLCUK For: Dec 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ADRs End Lower, Amarin and ArcelorMittal Trade Actively
ADRs End Lower, Amarin and ArcelorMittal Trade Actively...…
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
-- Amarin Continuing Process for Obtaining National Pricing and Reimbursement in Switzerland in the Course of 2023 -- -- Swissmedic…
Form 8-K AMARIN CORP PLCUK For: Dec 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Amarin (AMRN) Stock Might be a Great Pick
Amarin (AMRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as…
Form 8-K AMARIN CORP PLCUK For: Nov 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Amarin Stock Was a Winner Today
The product most readily identified with the company will soon hit pharmacy shelves in Australia....…
Amarin wins regulatory nod in Australia for heart disease therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
-- VAZKEPA® Approved in Australia to Reduce the Risk of CV Events in Adult Statin-Treated Patients with High CV Risk…
Amarin ADRs Rise 14% on Heart Disease Study Results
Amarin ADRs Rise 14% on Heart Disease Study Results...…
Amarin adds 13% as independent study supports heart disease therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
Amarins (AMRN) Vascepa sales decline year over year amid rising generic competition and the restructuring initiatives in the third quarter.…
Amarin (AMRN) Q3 2022 Earnings Call Transcript
AMRN earnings call for the period ending September 30, 2022....…
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
-- U.S. Business Trends Stabilize and Progress on Operational Initiatives Result in Extended Cash Runway -- -- Commenced Launch of…
Form 10-Q AMARIN CORP PLCUK For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AMARIN CORP PLCUK For: Oct 27
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin reports Q3 mixed earnings; continues to suspend 2022 revenue guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AMARIN CORP PLCUK For: Oct 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that…
Activist Sarissa Demands Special Meeting at Amarin to Hold Board Vote
An activist investment firm focusing on the pharmaceutical sector has put pressure on Amarin to hold a special meeting to straighten…
Amarin Board Defends Director Search Efforts After Investor Challenge
Amarin Board Defends Director Search Efforts After Investor Challenge...…
Amarin Board of Directors Issues Statement in Response to Sarissa
-- Highlights Active Board Refreshment Process -- -- Amarin Has Engaged Proactively and Frequently with Sarissa --...…